Top Markets
Coin of the day
Damora Therapeutics, Inc. Damora Therapeutics, Inc.

Damora Therapeutics, Inc.

DMRA
Kedudukan dalam Saham #6696
Galecto, Inc. is a clinical-stage biotechnology company dedicated to pioneering... Galecto, Inc. is a clinical-stage biotechnology company dedicated to pioneering innovative small molecule therapeutics. These treatments are specifically engineered to address core biological pathways implicated in both cancer and fibrotic disorders. The firm is also actively developing small molecule inhibitors targeting galectin-3 and LOXL2. Established in 2011 by Ulf Jรถrgen Nilsson, Hakon Leffler, Tariq Sethi, and Hans Thalsgรฅrd Schambye, its corporate operations are based in Boston, Massachusetts.
Harga Saham
$30.90
Disegerakkan terakhir: 2026-08-27
Modal Pasaran
$1.90B
Perubahan (1 hari)
1.68%
Perubahan (1 tahun)
859.63%
Negara
US
Perdagangan Damora Therapeutics, Inc. (DMRA)

Kategori

Sejarah pecahan saham untuk Damora Therapeutics, Inc. (DMRA)
Saham Damora Therapeutics, Inc. (simbol: DMRA) telah mengalami sejumlah 0 pecahan saham.
Pecahan saham terkini berlaku pada Aug 28, 2026.
Satu saham DMRA yang dibeli sebelum Aug 28, 2026 kini bersamaan dengan 0 saham DMRA.
Senarai pecahan saham
Tahun Pecahan Gandaan Gandaan Kumulatif
Tidak cukup data untuk tarikh yang disediakan.
Pecahan saham untuk syarikat pesaing atau serupa
Syarikat Bilangan pecahan saham Gandaan Kumulatif Negara
1 x2
US
0 -
NL
1 x3
AU
0 -
US
0 -
CH